Oncology | The Discreet Pharmacist

December 16, 2024

Published by TDP on December 16, 2024

Pediatric Oncology: Bone Marrow Transplantation and ALL Management

Explore our comprehensive educational series on bone marrow transplantation and pediatric acute lymphoblastic leukemia (ALL) management. This series delves into the intricacies of bone marrow transplantation, including the transplant process, conditioning regimens, and the critical role of immunosuppressants. Additionally, it covers the management of pediatric ALL, focusing on risk stratification, genetic risk groups, and innovative therapies such as immunotherapy and targeted treatments.

December 8, 2024

Published by TDP on December 8, 2024

New Hope for Patients with Limited-Stage Small Cell Lung Cancer: FDA Approves IMFINZI

The FDA approval of IMFINZI for limited-stage small cell lung cancer is a momentous step forward, offering a much-needed new treatment option for patients facing this aggressive disease. As the first immunotherapy regimen approved in this setting, IMFINZI has the potential to redefine care and significantly improve outcomes. This milestone underscores the importance of continued research and innovation in the fight against lung cancer.

October 11, 2024

Published by TDP on October 11, 2024

Introduction to CDK4/6 Inhibitors

CDK4/6 inhibitors have emerged as a pivotal component in the treatment of metastatic hormone receptor-positive breast cancer. These inhibitors are recognized as the standard of care, […]